Assessment of the HScore as a predictor of disease outcome in patients with COVID-19

Severe coronavirus disease 2019 (COVID-19) accompanies hypercytokinemia, similar to secondary hemophagocytic lymphohistiocytosis (sHLH). We aimed to find if HScore could predict disease severity in COVID-19. HScore was calculated in hospitalized children and adult patients with a proven diagnosis of...

Descripción completa

Detalles Bibliográficos
Autores principales: Bordbar, Mohammadreza, Sanaei Dashti, Anahita, Amanati, Ali, Shorafa, Eslam, Mansoori, Yasaman, Dehghani, Seyed Javad, Molavi Vardanjani, Hossein
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8555714/
https://www.ncbi.nlm.nih.gov/pubmed/34715834
http://dx.doi.org/10.1186/s12890-021-01706-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8555714/
https://www.ncbi.nlm.nih.gov/pubmed/34715834
http://dx.doi.org/10.1186/s12890-021-01706-0

Ejemplares similares